ABSTRACT: Standard treatments of adult acquired flatfoot deformity (AAFD) fail to correct associated dysfunction of the posterior tibial tendon (PTT). This study aimed to determine if a novel passive engineering mechanism (PEM) enhanced flexor digitorum longus (FDL) tendon transfer procedure would better restore physiologic PTT function to improve AAFD gait parameters compared to standard treatment. We evaluated the kinetic, pedobarographic, and kinematic effects of a pulley-based PEM-enhancement system utilizing a cadaveric flatfoot model and robotic gait simulator. FDL tendon force, FDL tendon excursion, regional peak plantar pressures, center of pressure, and foot bone/joint motions were quantified. Throughout the stance phase of gait, PEM-enhancement significantly increased FDL tendon forces, resulting in gait cycle medial column unloading, lateral column loading, forefoot adduction, hindfoot inversion, and increased plantar flexion (p < 0.05). This proof-of-concept study demonstrated that an innovative PEM-enhanced FDL tendon transfer procedure better restored physiologic PTT function, resulting in improved correction of the distinctive AAFD gait characteristics-medial column collapse, hindfoot eversion, and forefoot abduction. Clinical significance: Novel PEM-enhancement of a FDL tendon transfer procedure holds promise as a method for improved treatment of AAFD. ß
Adult acquired flatfoot deformity (AAFD), an increasingly prevalent orthopaedic foot and ankle problem, is associated with posterior tibial tendon dysfunction (PTTD). [1] [2] [3] The posterior tibial tendon (PTT) is the primary dynamic stabilizer of the medial longitudinal arch and a key contributor during the stance phase (SP) of gait, as it elevates the arch and inverts, adducts, and plantar flexes the foot. 4, 5 PTTD results in the transfer of non-physiologic forces through the foot leading to attenuation of supportive soft-tissue structures, excessive peroneal and Achilles tendon action, and the distinctive flatfoot deformity, which is characterized by collapse of the medial longitudinal arch, hindfoot eversion, and forefoot abduction. [5] [6] [7] [8] Age-related degeneration leading to tendon elongation or rupture is the prevailing cause of PTTD, though studies have identified multiple etiologies. [8] [9] [10] [11] [12] Diagnosis commonly incorporates a 4-stage classification system to guide prognosis and treatment. 5, 6, 13 Stage II PTTD, the model of this study, is an intermediate stage characterized by rupture or advanced attenuation of the PTT and passively correctable forefoot abduction and hindfoot eversion. 5, 13 Standard Stage II PTTD interventions include tendon transfer, soft tissue repair, gastrocnemius recession, and a variety of bony procedures, though controversially no consensus treatment has been established. 5, [14] [15] [16] [17] Current methods generally produce durable symptomatic relief and moderate clinical improvement, but fail to re-establish physiologic PTT function. [18] [19] [20] [21] Flexor digitorum longus (FDL) tendon transfer, the procedure of interest in this study, replaces or supplements a pathologic PTT with the FDL, an inferior musculotendinous unit with only 28% relative strength. 4, 5, 8, 22 Thus, post-operative support of the medial longitudinal arch remains significantly reduced in comparison to an unaffected contralateral limb despite FDL hypertrophy and/or partial PTT recovery following transfer. [22] [23] [24] [25] It has been hypothesized that treatment failure may be associated with this muscular imbalance, however, no approach yet exists to fully restore physiologic PTT function. 18, 20, 26, 27 An innovative method to enhance tendon transfers utilizes passive engineered mechanisms (PEMs), such as pulleys and linkages, which provide differential action or mechanical advantage by design. Recently, Mardula et al. 28 demonstrated that implanted pulleys can be used to address limitations of an extensor carpi radialis tendon transfer by transmitting differential movement between fingers for enhanced dexterity. The efficacy of utilizing a pulley as a device that provides mechanical advantage (such as force-scaling) in a tendon transfer procedure holds promise, but has not yet been established.
The objective of this proof-of-concept study was to determine if a novel PEM-enhanced FDL tendon transfer procedure improves treatment of Stage II PTTD. To quantify improvement, we sought to characterize the pedobarographic and kinematic effects of PEMenhancement using a cadaveric flatfoot model and a robotic gait simulator (RGS). [29] [30] [31] [32] [33] We hypothesized that PEM-enhancement would increase the PTT force applied to the medial longitudinal arch to better restore physiologic gait parameters. Specifically, we hypothesized that PEM-enhancement would reflect a lateral shift in peak plantar pressure and center of pressure, as well as generate foot adduction, inversion, and plantar flexion when compared to a flatfoot control and standard FDL tendon transfer treatment.
METHODS

Radiographic Measures
Eight fresh-frozen cadaveric lower-limb specimens (6M, 2F, 56-85 years, 59.1-88.6 kg) were obtained from the University of Washington Department of Biological Structures and Lonetree Medical Donation, LLC. Specimens were transected midtibia and placed in a custom tibia-loading device. Radiographs [anterior/posterior (AP), medial/lateral (ML), and hindfoot] were taken with specimens loaded to 25% body weight (BW) to assess baseline foot type. Radiographs were distortion corrected and standard radiographic measurements assessed in AAFD diagnosis were measured by three raters using Matlab (The MathWorks; Natick, MA). [34] [35] [36] [37] Radiographs were evaluated to ensure that specimens did not possess any preexisting mid-or hindfoot pathologies. Any specimen with significant pathological abnormalities, such as pes cavus, was excluded.
Flatfoot Induction
A flatfoot model consistent with Stage II PTTD was induced by attenuating ligaments involved in flatfoot deformity and applying a cyclical axial load. 30 The anterior component of the superficial deltoid, talocalcaneal interosseus, plantar naviculocuneiform, and plantar first metatarsocuneiform ligaments were attenuated by making multiple incisions parallel to their fiber orientation. Additionally, the dorsal talonavicular joint capsule and spring ligament complex were transected. Cutaneous incisions were closed via suture. Specimens were mounted to a mechanical test system (MTS Mini Bionix 858; Eden Prairie, MN) with a 40˚heel wedge placed beneath the posteromedial aspect of the hindfoot to enhance calcaneal eversion. 33 An approximately 90 N force was applied to the Achilles' tendon using a clamp and directional pulley system to better reflect physiologic tendon loading during gait. Each specimen was preloaded to 130 N and cycled to 120% of the donor's BW at 2 Hz until flatfoot changes were grossly observed (150,000 cycles). Loading forces were selected to simulate physiologic loads experienced during gait. 38 A postflattening series of radiographs were taken to confirm flatfoot deformity induction ( Fig. 1 ; Table 1 ).
Robotic Gait Simulation
In preparation for gait simulation, tibial dissection and kinematic marker attachment were performed. Soft tissue proximal to the malleoli was removed to isolate the nine extrinsic tendons of the foot: anterior tibialis, extensor digitorum longus, extensor hallicus longus, peroneus longus, peroneus brevis, posterior tibialis, FDL, flexor hallicus longus, and the Achilles. Anchors (lock-nuts) were proximally affixed to the isolated tendons to provide an attachment point for the RGS muscle actuators via a terminal poly-cord clove hitch. A 10-segment, 40-marker foot model was applied using retro-reflective markers or marker quad-clusters affixed to screws in the tibia, fibula, calcaneus, talus, navicular, cuboid, medial cuneiform, first metatarsal, third metatarsal, and fifth metatarsal. 31 Cutaneous hallux markers were placed on the dorsal base, dorsal head, and medial head of the first phalanx. Specimens were fitted with a custom tibiamounting device and affixed to the RGS.
The RGS is composed of a R2000 6-degree of freedom parallel robot (Mikrolar, Inc.; Hampton, NH), force plate (Kistler Instrument Corp.; Amherst, NY), nine linear tendon force actuators (Exlar Corp., Chanhassen, MN) with in-series load cells (Transducer Techniques Inc., Temecula, CA), a real time PXI embedded controller (National Instruments Corp., Austin, TX), and a computer interface (Fig. 2) . 29 To simulate stance phase, the RGS moves the force plate (i.e., the ground) to create inverse motion with respect to the fixed cadaveric tibia while synchronously applying dynamic tensile forces to the extrinsic tendons via the actuator-load cell systems and proportional-integral-derivative (PID) controllers. Tibia to ground kinematics were prescribed using in vivo data from 10 subjects (4M, 6F, 41-63 years, 58.1-86.2 kg) with radiographically confirmed neutral feet (i.e., no planus or cavus deformity), while dynamic tendon force targets were estimated from the literature. 31 A fuzzy logic controller altered the tibia kinematics (iteratively) and the Achilles and anterior tibial tendon forces (real time) to allow the in vitro vertical ground reaction force (vGRF) to accurately track the in vivo target vGRF. To protect the cadaveric specimens, target tendon forces and vGRF were scaled to 50% BW and stance phase simulations were completed in 4.09 s (1/6 the speed of physiologic gait). For each simulation, a quartet of three learning trials (enabling iterative improvement in in vivo gait parameter targeting) and one final data collection trial were performed.
Each specimen was tested on the RGS under five conditions in randomized order: flatfoot (FF), FDL tendon transfer (FDLTT), hypertrophic FDLTT (hFDLTT), PEM, and hypertrophic PEM (hPEM). In the control condition (FF), no muscle force was applied to the posterior tibial tendon to simulate dysfunction characteristic of Stage II PTTD. In the standard FDL tendon transfer treatment (FDLTT, hFDLTT) and PEM-enhanced FDL tendon transfer treatment (PEM, hPEM) conditions, application of FDL muscle force to the PTT was used to simulate an FDL tendon transfer procedure to enable randomization and minimize specimen modification during testing. Additionally, force was not applied to the FDL tendon. In hypertrophic conditions (hFDLTT, hPEM), FDL force was increased by 44% to simulate FDL muscle hypertrophy following tendon transfer. 23 In PEM conditions, a customized commercial simple pulley (1.27 cm diameter) was attached to the PTT proximal to the medial malleolus along the tendon's physiologic ENGINEERED FDL TENDON TRANSFER ENHANCEMENT line of action to establish a free-floating pulley-tendon system (Fig. 3) . A synthetic cord attached to the FDL tendon actuator was routed through the pulley and secured to the RGS tibia mount. Five kinematic markers were affixed to the pulley system to record FDL tendon actuator excursion and pulley displacement for comparison to physiologic values. 39 Three simulation quartets were collected for each condition per specimen for a total of 120 simulation quartets. Pedobarographic measures were collected with a pressure mat (pliance, novel electronics, inc.; St. Paul, MN) mounted to the RGS force plate and analyzed using novel software and a custom Matlab program. Pedobarographic data was aligned with a modified AP radiograph to isolate the hindfoot, medial midfoot, lateral midfoot, metatarsals (1-5), hallux, and lesser toes to assess regional peak plantar pressure and center of pressure (CoP). CoP was normalized by foot length and width.
Foot bone kinematics were measured using an eightcamera motion capture system (Vicon; Lake Forest, CA) synchronized to the RGS and the previously described 10-segment foot model. Marker trajectories were processed using the Woltring filter (mean square error of 20). Joint motion during stance phase in the coronal, sagittal, and transverse planes were calculated for the tibiotalar, subtalar, talonavicular, naviculocuneiform, calcaneocuboid, first tarsometatarsal (TMT), first metatarsophalangeal (MTP), and fifth TMT joints, as well as the first metatarsal to talus relationship using a custom Vicon Body Builder program.
To measure PEM force scaling, independent RGS testing was completed with a 1kN load cell (Omegadyne Inc.; Sunbury, OH; accuracy AE2.5 N) attached in-series with the pulley and PTT (Fig. 3) . Scaled FDL forces were continuously measured with a custom LabVIEW program (National Instruments Corp.; Austin, TX). Five simulation quartets were collected for five specimens for a total of 25 simulation quartets.
Statistical Analysis
A priori, the sample size (n ¼ 8) was selected to detect significant differences in CoP with 80% confidence (power ¼ 0.80) based off of literature data. 33 Linear mixed effects regression was used to determine if the mean radiographic outcomes (the dependent variables) differed after flatfoot induction (the independent fixed effect) with specimen and specimen by condition interaction as random effects. Type one error was set at p 0.05. Linear mixed effects regression was used to determine if the mean the biomechanical outcomes (dependent variables: peak plantar pressure, CoP, kinematic measures) differed by condition (independent fixed effect), with specimen and specimen by condition interaction where appropriate, as random effects. An omnibus test was first completed to determine if there was a significant association between dependent variables and independent fixed effects. If so, pair-wise comparisons were carried out (FDLTT-FF, hFDLTT-FF, PEM-FF, hPEM-FF, PEM-FDLTT, and hPEM-hFDLTT) using simultaneous inference. 40 For omnibus tests of kinematic measures, p-values were adjusted for multiple comparisons using the Benjamini and Hochberg method. 41 For both omnibus and pair-wise tests of kinematic measures, significance was limited to continuous differences greater than 5% of stance phase. A paired t-test was used to determine if mean PEM force scaling differences were significant. Significance was set at p < 0.05. All analyses were performed using R 3. 
ENGINEERED FDL TENDON TRANSFER ENHANCEMENT
RESULTS
The flattening procedure produced mean changes in radiographic measures consistent with flatfoot deformity (Table 1 ). Significant differences were observed: The calcaneal pitch decreased, the talus plantar flexed relative to the first metatarsal, the navicular height decreased, the navicular abducted relative to the talus, and the calcaneus everted.
The RGS accurately simulated in vivo gait data across all trials for vGRF, tibia to ground kinematics, and applied tendon forces. In vitro vGRF root mean square (RMS) error from the target data averaged 5.1% BW (Fig. 4A) . In vitro tibia to ground kinematics in all planes approximated the target data AE 0.01 standard deviation (SD) (Fig. 4B) . Mean in vitro extrinsic tendon force RMS error was 2.78 AE 0.42 N (fuzzy logic controlled tendons excluded) (Fig. 4C) .
Throughout stance phase, PEM-enhancement significantly increased applied FDL tendon forces (Fig. 5 ) while reflecting physiologic tendon action. Mean FDL force at its physiologic dynamic force curve peak (82% stance phase) increased 32.6 AE 10.7%. Maximum FDL tendon actuator excursion and pulley translation along the tibia averaged 9.07 AE 0.97 mm and 8.77 AE 1.33 mm respectively.
Pedobarographic data demonstrated that PEM-enhancement increased lateral pressure and decreased medial pressure during stance phase. Specifically, PEMenhancement significantly shifted CoP laterally in comparison to flatfoot (25%, 50%, and 90% stance phase) and standard treatment (25%, 50%, and 90% stance phase). Comparatively, only general lateralizing CoP trends were observed for all other treatment conditions in comparison to flatfoot (Table 2, Fig. 6 ), with the exception of significant shifts observed for standard treatment at 25% and 50% stance. CoP at 25% and 50% stance phase were equivalent within each trial. In addition, general, non-significant trends suggested that peak plantar pressure increased in the lateral midfoot and forefoot (fourth and fifth metatarsals), and decreased in the hindfoot, medial forefoot (first, second, and third metatarsals), hallux, and lesser toes (second through fifth phalanges) for all treatment conditions in comparison to flatfoot (Table 3 , Fig. 7 ). PEM-enhancement significantly decreased peak hindfoot pressures compared to flatfoot and standard treatment.
Kinematic data indicated that PEM-enhancement caused adduction, inversion, and elevation of the medial longitudinal arch during stance phase (Table 4 , Fig. 8, Supplementary Figures S1-S9 ). Significant differences in joint kinematics were observed for PEM-enhanced treatment in comparison to flatfoot for the tibiotalar (1.5-2˚adduction), talonavicular (1.5-2.5˚inversion, 1.5-4˚adduction), naviculocuneiform ($1˚plantar flexion), calcaneocuboid ($1˚adduction), and first MTP (1-2˚eversion) joints, as well as the relationship between the first metatarsal and talus (1-3i nversion, 1-2.5˚adduction). In addition, significant differences occurred for PEM-enhanced treatment in comparison to standard treatment for the tibiotalar (1-1.5˚adduction), naviculocuneiform ($1˚plantar flexion), and first MTP ($1˚eversion) joint motions. FDLTT exhibited significant eversion ($1˚) of the first MTP joint in comparison to flatfoot.
DISCUSSION
Adult acquired flatfoot deformity associated with posterior tibial tendon dysfunction remains a common orthopaedic problem for which a definitive solution has yet to be identified. [1] [2] [3] Controversy has surrounded the diversity of treatment approaches utilized in current practice, which collectively attempt to mitigate a consensus weakness of PTTD treatment, that is, an inability to restore physiologic posterior tibial tendon function. 5, [14] [15] [16] [17] [18] [19] [20] [21] In this proofof-concept study, we proposed a novel PEM-enhanced FDL tendon transfer to address this deficiency (Fig. 9) . Using a biomechanical flatfoot model, we characterized the pedobarographic and kinematic effects of PEM-enhancement during the stance phase of gait. [29] [30] [31] [32] [33] As hypothesized, we found that PEMenhancement increased the force applied to the medial longitudinal arch and caused a lateral shift in peak plantar pressure and CoP, as well as joint adduction, inversion, and plantar flexion when compared to flatfoot and standard treatment.
Cadaveric flatfoot induction and robotic gait simulation produced a biofidelic flatfoot model. Analysis of radiographic measures showed that post-flattening changes were consistent with flatfoot deformity, with four of the five measures (LTMA, NH, TNCA, CED) (Fig. 4) . In comparison to previous biomechanical flatfoot studies, our methods produced greater average changes across radiograph measures and showed comparable RGS validation metrics. 30, 33, 44, 45 PEM-enhancement better restored physiologic PTT force in comparison to standard treatment, and did so within physiologic excursion limits. At peak FDL tendon activity (82% stance phase), the mean PEM force magnification of 32.6% resulted in a 65.1% restoration of PTT force to the medial longitudinal arch versus 49.3% without. Given known limitations (i.e. non-axial loading) of the method applied to collect this data, we believe this observed value underestimates the degree of PTT force restoration realized in full simulation trials where these limiting factors were minimized by the free-floating pulley design. In full trials, tendon excursion requirements for generating PEM force-magnification did not exceed physiologic FDL limits, as the average maximum excursion with PEM-enhancement represented 73.9% of the 12.4 mm physiologic mean established by Hintermann et al. 39 Pulley translation along the tibia reflected physiologic tendon action and corresponded to 70.7% of the 12.4 mm mean. Importantly, these results demonstrate that the trade-off of PEM force-magnification for decreased distal excursion, specified by the principle of conservation of energy and work, did not hinder medial longitudinal arch restoration. These findings suggest that the FDL musculotendinous unit is suitable for PEM-enhancement. Specifically, given the the force-scaling provided by the pulley (1.34Â), the pulley's reduced movement (70.7%) with respect to the FDL contraction matches what is expected from mechanics theoretical computation (close to 1/1.34Â ¼ 75.4%).
Analysis of pedobarographic and kinematic data demonstrated that PEM-enhancement better restored physiologic gait compared to standard treatment. Medial column unloading and compensatory lateral column loading reflected by the CoP and peak plantar pressure results (Tables 2 and 3 ) indicated that PEMenhancement enabled desired medial longitudinal arch elevation along the PTT's navicular and mid-tarsal insertions. Significant kinematic differences (Table 4) signaling forefoot/midfoot adduction (tibiotalar, talonavicular, calcaneocuboid, 1st metatarsal to talus), midfoot inversion (talonavicular, metatarsal to talus, compensatory 1st MTP eversion), and elevation of the medial longitudinal arch (naviculocuneiform plantar flexion) also indicated that PEM-enhancement was necessary to generate desired changes to stance phase joint motions. In considering the generally non-significant effects of standard FDL tendon transfer, our results are consistent with previous studies which concluded that the procedure appears to have only a minor effect on altering pedobarographic parameters in the absence of a concomitant bony procedure. 33, [45] [46] [47] Uniquely, PEM-enhancement enabled expected pedobarographic and kinematic differences not seen by previous investigators. 33, 47 Additionally, these differences compare to those found by other studies which applied combined procedures to achieve desired changes. 16, 45, 48 Several limitations affected this study. Our cadaveric flatfoot model, simulated FDLTT procedure, and robotic gait simulation trials only approximated in vivo conditions. Additionally, measurement of PEM force scaling was affected by the aforementioned factors and the pulley design was not indicative of a device suitable for surgical use. Furthermore, potential effects of condition testing order were not directly examined, though testing order randomization was employed and condition design was devised to minimize the changes required between conditions. Future work will apply our proof-of-concept results to engineer a biocompatible and significantly more compact pulley and tendon sheath system. With improved PEM-system components, we will additionally define an optimal position for surgical implantation to achieve loading directions that provide maximal scaling while minimizing the potential for long-term physiologic relaxation of the musculotendinous unit.
The results of this study validate the efficacy of a PEM-enhanced FDL tendon transfer in improving Stage II PTTD characteristics compared to standard treatment. While the PEM helps restore aspects relating to the center of presssure, foot adduction, and foot inversion, additional intervention may be necessary to help restore joint kinematics also. We believe the results of this study suggest that a PEM-enhanced FDL tendon transfer may be a valuable feature of novel approaches to improve outcomes in AAFD treatment. Further, this study establishes PEM-enhancement as an efficacious dynamic tendon force scaling method.
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